Risk Markers of Arterial Aging. The Paris Prospective Study III-2

ConditionArterial Stiffness

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age60-95

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

About this trial

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Eligibility criteria

Qualifiers

Being enrolled in PPS3 and having signed an informed consent for PPS3-2

Disqualifiers

Institutionalized participants

Participants under guardianship

Participants under judicial safeguard measure

Trial design

Treatments tested in this trial

high-precision carotid echo-tracking

Treatment groups

7,500 Participants

are divided into 1 treatment group

Sponsors and collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor

Source ClinicalTrials.gov